IL17A and psoriasis: Thus, the discovery that RORγt regulates the development of multiple lymphocyte lineages including IL-17A-producing immune cell populations provides compelling evidence that disruption of the RORγt/IL-17A/IL-23 axis may represent a viable therapeutic option for the treatment of psoriasis.